Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Huanye Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and large-scale manufacturing of anti-infective agents. The company is a global leader in the production of macrolide antibiotics, including Clarithromycin, Azithromycin, and Roxithromycin, offering both active pharmaceutical ingredients (APIs) and finished dosage forms. Huanye operates advanced, GMP-compliant manufacturing facilities in Quzhou, Zhejiang, and maintains a strong presence in both the domestic Chinese market and international export markets. In addition to its core antibiotic business, the company produces medications for cardiovascular, digestive, and respiratory health. Their products are exported to numerous countries, supporting global healthcare needs for common bacterial infections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huan Ye.